No Data
shanghai shenqi pharmaceutical investment management (600613.SH): The shareholding ratio of Zhi Ji No. 2 has dropped to 4.99998%.
On December 2, Gelonhui learned that Shanghai Shenqi Pharmaceutical Investment Management (600613.SH) announced that on December 2, 2024, it received a "Simple Equity Change Report" and a "Notice of Reduction of Shares and Post-Reduction Shareholding Percentage to Below 5" issued by Zhi Ji 2. Zhi Ji 2 reduced the company's shares by 3,296,500 shares through centralized competitive trading on December 2, 2024. After this equity change, Zhi Ji 2's holding of the company's shares decreased from 30,000,000 shares to 26,703,500 shares, and the shareholding percentage decreased from 5.61722% to 4.99998%.
There May Be Some Bright Spots In Shanghai Shenqi Pharmaceutical Investment Management's (SHSE:600613) Earnings
Wonder Pharmaceuticals: Shanghai Magic Pharmaceutical Investment Management Co., Ltd. Report for the Third Quarter of 2024
Shanghai Magic Pharmaceutical Investment Management Co., Ltd. Report for the Third Quarter of 2024
Shanghai Magic Pharmaceutical Investment Management Co., Ltd. announced the main operating data for the third quarter of 2024
shanghai shenqi pharmaceutical investment management (600613.SH) released its performance for the first three quarters, with a net income of 59.3538 million yuan, a decrease of 10% year-on-year.
shanghai shenqi pharmaceutical investment management (600613.SH) released the report for the first three quarters of 2024, during which the company achieved revenue...
More Unpleasant Surprises Could Be In Store For Shanghai Shenqi Pharmaceutical Investment Management Co., Ltd.'s (SHSE:600613) Shares After Tumbling 26%
